About Savill Pharmalabs Pvt Ltd
Data last updated:
Savill Pharmalabs Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1986PTC038968. Its GSTIN is 27AABCS4443F1ZI (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Jayantilal Punamchand Jain and Devendra Jain Punamchand.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 20A Siddhpura Indl Estate S. V. Road Patel Petrol Pump Gali Goregaon (West), Mumbai, Maharashtra, India – 400062.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.06 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹45.09 Lakh (net margin 11.1%) and EBITDA of ₹70.81 Lakh (EBITDA margin 17.4%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 18% over five years.
The company is associated with 1 brand: Savill Pharma Labs. As per MCA filings, the company has satisfied charges of ₹3.12 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website savillpharma.com.
Company details
Contact details
Savill Pharmalabs Pvt Ltd's registered office is in Mumbai, Maharashtra. Its website is savillpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address20A Siddhpura Indl Estate S. V. Road Patel Petrol Pump Gali Goregaon (West), Mumbai, Maharashtra, India – 400062
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Savill Pharmalabs Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Savill Pharmalabs operates one associated brand: SAVILL PHARMA LABS. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of generic solid and liquid formulations | savillpharma.com |
Business activity
The main business activity of Savill Pharmalabs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Savill Pharmalabs Pvt Ltd, buy the company report.
Financials of Savill Pharmalabs Pvt Ltd
FY 2025 filings availableSavill Pharmalabs Pvt Ltd reported revenue of ₹4.06 Cr (up 45% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 45% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹70.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.4% | ||||
| Net Profit Margin | 11.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Savill Pharmalabs Pvt Ltd, buy the company report.
Board of directors of Savill Pharmalabs Pvt Ltd
Savill Pharmalabs has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayantilal Punamchand Jain | Director | 17 Feb 1986 | 40 Years 8 Months | Current |
| Devendra Jain Punamchand | Director | 29 Sep 2001 | 25 Years 1 Months | Current |
| Punit Jain Jayantilal | Director | 02 Jan 2017 | 9 Years 9 Months | Current |
| Jain Devendra Krutik | Director | 02 Jan 2017 | 9 Years 9 Months | Current |
Peer comparison
Savill Pharmalabs Pvt Ltd is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meditria Healthcare Private Limited | ₹4.08 Cr (FY 2020) | 11239.0% | Surendranagar, Gujarat, India | |||
| Noxxon Pharmaceuticals Private Limited | ₹4.07 Cr (FY 2024) | 44.0% | Mohali, Punjab, India | |||
| Savill Pharmalabs Pvt Ltdthis company | ₹4.06 Cr (FY 2024) | ₹45.09 Lakh | 11.1% | 45.0% | Mumbai, Maharashtra, India | |
| Haffkine Ajintha Pharmaceuticals Limited | ₹4.05 Cr (FY 2023) | 214.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Savill Pharmalabs Pvt Ltd, buy the company report.
Auditor
Savill Pharmalabs Pvt Ltd is audited by RAJMAL JAIN & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJMAL JAIN & CO | FY 2020 | 108465W |
Shareholding
The shareholding of Savill Pharmalabs Pvt Ltd is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Savill Pharmalabs Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jan 2018 | 100150518 | Others | ₹1.8 Cr | Satisfied | |
| 26 Feb 2006 | 90238083 | Bank of Baroda | ₹60 Lakh | Satisfied | |
| 16 Feb 2006 | 90235162 | Bank of Baroda | ₹60 Lakh | Satisfied | |
| 04 Nov 1989 | 90185519 | Bank of Baroda | ₹12 Lakh | Satisfied |
To see the full charge records of Savill Pharmalabs Pvt Ltd, buy the company report.
Total charge records: 4 View all charges
Legal cases
Savill Pharmalabs Pvt Ltd has 1 court case on record: 1 filed by Savill Pharmalabs. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons cases SS) | Filed by the company against an individual | Disposed |
To see the full case history of Savill Pharmalabs Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Savill Pharmalabs Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Savill Pharmalabs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCS4443F1ZI | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Savill Pharmalabs Pvt Ltd, buy the company report.
Recent activity
Savill Pharmalabs Pvt Ltd has 4 board changes on record since 1986: 4 appointments. The latest: Jain Devendra Krutik was appointed as Director on 02 Jan 2017.
3 earlier events are in the company report.
Frequently asked questions
Savill Pharmalabs is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 1986 (40+ years old) and is registered under CIN U24230MH1986PTC038968.
Savill Pharmalabs has 4 current directors:
- Jayantilal Punamchand Jain - Director
- Devendra Jain Punamchand - Director
- Punit Jain Jayantilal - Director
- Jain Devendra Krutik - Director
The latest financial statements of Savill Pharmalabs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Savill Pharmalabs is 27AABCS4443F1ZI, registered in Maharashtra.
The CIN (Corporate Identification Number) of Savill Pharmalabs is U24230MH1986PTC038968. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Savill Pharmalabs has 1 court case on record: 1 filed by the company.
Savill Pharmalabs was incorporated on 17 February 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Savill Pharmalabs by revenue are Meditria Healthcare Private Limited, Noxxon Pharmaceuticals Private Limited, Haffkine Ajintha Pharmaceuticals Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jain Devendra Krutik was appointed as Director on 02 Jan 2017. Punit Jain Jayantilal was appointed as Director on 02 Jan 2017. Devendra Jain Punamchand was appointed as Director on 29 Sep 2001. Savill Pharmalabs has 4 board changes on record in total.
Savill Pharmalabs can be reached through the website savillpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Savill Pharmalabs is at 20A Siddhpura Indl Estate S. V. Road Patel Petrol Pump Gali Goregaon West, Mumbai, Maharashtra, India – 400062.